Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.
FDA sets June decision deadline for potential full approval, label expansion of Sarepta’s Duchenne gene therapy
Sarepta Therapeutics could soon notch another regulatory win. Despite the company and its Duchenne gene therapy getting dogged by debate, and then a failed confirmatory